Clinical Trial Update: Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating methotrexate-based chemo-immunotherapy followed by maintenance therapy in patients over 65 with primary central nervous syst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Primary Non Hodgkin Lymphoma of the Central Nervous System | Phase 2 | Status: UNKNOWN